Elite in IgG4-Related Disease

Yoshiya K. Tanaka

Kitakyushu, JP 
Elite in IgG4-Related Disease
Kitakyushu, JP 
OverviewLocationsClinical Research

Overview

Yoshiya Tanaka practices in Kitakyushu, Japan. Tanaka is rated as an Elite expert by MediFind in the treatment of IgG4-Related Disease. Their top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Systemic Lupus Erythematosus (SLE), Liver Transplant, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 1090 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 20 articles in the study of IgG4-Related Disease.

Locations

Kitakyushu, Japan
Other Locations
Japan
Fukuoka, Japan
Shimonagakubo, 4118777, Japan
Osaka, Japan
Wakayama, 6408222, Japan
Kashihara-shi, 6348521, Japan
Kyoto, 6078414, Japan
Wako, Japan
Saitama, 3510198, Japan
Kashiwa, 2778561, Japan
Tokorozawa, 3598513, Japan
Gifu-shi, Japan
Toyoake, Japan
Kitakyushyu Shi, 8078555, Japan
Tokyo, Japan
Obihiro, Japan
Toyonaka, 5600043, Japan
Nagoya, 4648601, Japan
Nara-shi, Japan
Kashihara, Japan
Iseigaoka, 8078555, Japan
Ube, Japan
Kobe, Japan
Hiroshima, Japan
Kofu, Japan
Tsukuba, Japan
Hirosaki, Japan
Yokohama, Japan
Yayoi, 1138657, Japan
Minato, Japan
St Marianna University School Of Medicine, Kawasaki, Japan
Ichikawa, Japan
Kamigori, 6781297, Japan
Sendai, Japan
Kamisokoino, 8090003, Japan
Yamaguchi, Japan
Sayo, Japan
Itabashi, 1738610, Japan
Matsuyama, Japan
Sakai, 5918025, Japan
Higashiyamato, Japan
Sagamihara, Japan
Kure, 7370112, Japan
Nagasaki, Japan
Iizuka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1086 Total Publications

Comment on: Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: reply.
Comment on: Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: reply.
Journal: Rheumatology (Oxford, England)
Published: August 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tanaka's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 12 Distinguished Conditions
View All 36 Advanced Conditions
View All 131 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile